Explore

Low Adherence to Brain Health Advice Among Early Alzheimer's Patients

Low Adherence to Brain Health Advice Among Early Alzheimer's Patients

A study by the Mass General Brigham Neuroscience Institute reveals that most patients with early Alzheimer's disease are not adhering to brain health recommendations. The study, published in The Journal of Prevention of Alzheimer's Disease, found that fewer than 3% of patients followed all 15 brain health recommendations. This includes patients pursuing treatment with lecanemab, an anti-amyloid antibody medication, and those not pursuing such therapy. The findings highlight a gap in the implementation of lifestyle changes that could potentially slow cognitive decline.

Alzheimer's Drug Study Shows Potential in Reducing Brain Damage

Alzheimer's Drug Study Shows Potential in Reducing Brain Damage

A rare study of a human brain has provided insights into how an Alzheimer's drug may protect the brain by clearing amyloid plaques. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that regions of the brain treated with anti-amyloid drugs showed reduced tau protein accumulation, which is associated with neuron loss and cognitive decline. This study, presented at the 2026 Alzheimer’s Association International Conference, offers evidence that removing amyloid plaques may interrupt the progression of Alzheimer's disease.

Study Reveals Diverse Inflammatory Processes in Alzheimer's Disease, Impacting Treatment Approaches

Study Reveals Diverse Inflammatory Processes in Alzheimer's Disease, Impacting Treatment Approaches

A study led by researchers at the University of California, Irvine, has identified two distinct inflammatory patterns in Alzheimer's disease, each associated with different biological processes. One pattern involves damage to the brain's small blood vessels, while the other is linked to amyloid-beta buildup. Both patterns are connected to higher levels of a blood marker associated with abnormal tau, leading to brain shrinkage and memory loss. The findings suggest that Alzheimer's disease may not be driven by a single process, but rather by a combination of factors, which could explain the varied responses to treatments among patients.

Study Links Multimorbidity to Cognitive Decline and Alzheimer's Biomarkers in U.S. Adults

Study Links Multimorbidity to Cognitive Decline and Alzheimer's Biomarkers in U.S. Adults

A study involving 3,808 dementia-free participants from the Health and Aging Brain Study: Health Disparities has found that a higher burden of multimorbidity is associated with worse cognitive function and increased levels of Alzheimer's disease biomarkers. The research, conducted by a team from various U.S. institutions, assessed the impact of multiple chronic conditions on cognition and biomarkers related to Alzheimer's pathology, neurodegeneration, and cerebral small vessel disease. The study highlights the complex relationship between multimorbidity and cognitive decline, emphasizing the need for a holistic approach to managing chronic diseases to potentially delay cognitive deterioration.

Research Highlights Hormonal and Genetic Factors in Alzheimer's Risk for Women

Research Highlights Hormonal and Genetic Factors in Alzheimer's Risk for Women

Research Highlights Hormonal and Genetic Factors in Alzheimer's Risk for Women

Creatine Shows Potential for Brain Health, But Evidence Remains Preliminary

Creatine Shows Potential for Brain Health, But Evidence Remains Preliminary

Creatine Shows Potential for Brain Health, But Evidence Remains Preliminary

Swedish Neuroscientist Challenges Long-Held Belief on Adult Brain Neurogenesis

Swedish Neuroscientist Challenges Long-Held Belief on Adult Brain Neurogenesis

In 1998, Swedish neuroscientist Peter Eriksson, alongside Fred Gage from the Salk Institute, published groundbreaking research indicating that adult human brains can generate new neurons. This discovery was based on tissue samples from cancer patients who had been injected with a DNA tracer, revealing newly dated cells in the hippocampus. The study challenged the long-standing belief, established by Santiago Ramón y Cajal, that adult brains do not produce new neurons. Despite initial skepticism, subsequent research has supported Eriksson's findings, although debates continue regarding the extent and significance of adult neurogenesis.

Advancements in Alzheimer's Treatment Highlight Modifiable Risk and Early Detection

Advancements in Alzheimer's Treatment Highlight Modifiable Risk and Early Detection

Recent developments in Alzheimer's treatment emphasize the importance of modifiable lifestyle changes and early detection in managing the disease. According to a report, 40% of the risk for Alzheimer's and other dementias is modifiable, suggesting that lifestyle changes can significantly impact disease prevention and progression. New immunotherapies have been developed to remove amyloid plaques from the brain, which can slow cognitive decline by up to 27% over an 18-month treatment period. Early detection tools, such as brain imaging, genetic testing, and new blood tests, are crucial in identifying Alzheimer's at its earliest stages, allowing for timely interventions and participation in clinical trials.

Study Links Excessive Television Watching to Potential Brain Health Risks

Study Links Excessive Television Watching to Potential Brain Health Risks

A recent study has found that individuals who frequently watch television may experience reduced brain volume in areas associated with cognitive control and language. The research, funded by the National Institutes of Health, involved over 1,700 middle-aged participants who reported their television viewing habits and time spent sitting at work. The study revealed that those who watched television 'very often' had smaller brain volumes and more white matter hyperintensities, which are linked to cognitive decline and dementia. Interestingly, sedentary behavior at work did not show the same negative brain changes, suggesting that not all sedentary activities have the same impact on brain health.

New Theory Suggests Infection May Be Linked to Alzheimer's Disease

New Theory Suggests Infection May Be Linked to Alzheimer's Disease

A new theory suggests that Alzheimer's disease may be linked to an infection caused by the bacterium Porphyromonas gingivalis, commonly associated with gum disease. Researchers have found this bacterium in the brains of Alzheimer's patients, challenging the traditional view of the disease as solely a neurodegenerative condition. The discovery raises the possibility that oral hygiene could play a role in preventing Alzheimer's, as the bacterium may enter the brain through the bloodstream. This theory is supported by studies showing increased beta-amyloid proteins in mice infected with the bacterium.

NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

A study funded by the National Institutes of Health (NIH) has discovered a significant shift in the immune environment of the hippocampus, a brain region crucial for learning and memory. This shift begins around age 50 and may contribute to the persistent brain inflammation seen in neurodegenerative diseases like Alzheimer's. Researchers found that microglia, the brain's primary immune cells, decline from age 50 to 75, replaced by cells with stronger inflammatory signals. The study utilized advanced single-cell methods to analyze postmortem hippocampal tissue, revealing changes in immune cell identity and origin that were previously hidden.

New Study Confirms Adult Human Brain's Ability to Generate Neurons, Challenging Long-Held Beliefs

New Study Confirms Adult Human Brain's Ability to Generate Neurons, Challenging Long-Held Beliefs

A recent study published in the journal Science has provided compelling evidence that the adult human brain can generate new neurons, a process known as neurogenesis. This finding challenges the long-standing belief that humans are born with a finite number of neurons. Researchers utilized advanced technologies, including single-cell RNA sequencing and artificial intelligence, to examine the hippocampus, a critical brain region for memory and learning. The study analyzed over 400,000 cell nuclei from individuals ranging from newborns to 78 years old. The results indicate that neurogenesis continues into adulthood, except in individuals with Alzheimer's disease. This discovery could have significant implications for understanding neurodegenerative diseases and cognitive potential throughout life.